Assessing the efficacy and safety of Brazikumab in the treatment of Ulcerative Colitis

Researchers at Synexus are looking for clinical trial volunteers who have been diagnosed with Ulcerative Colitis to take part in a study researching new treatments.

THE RECRUITMENT FOR THIS STUDY IS SUSPENDED DURING THE CORONAVIRUS OUTBREAK.

Thank you for your interest in this study – this page will be updated when it is re-open for recruiting. In the meantime, please see other opportunities to take part here and follow us on Twitter for the latest updates.


This new study funded by Allergan will assess the efficacy of brazikumab in patients with moderately and severely active Ulcerative Colitis.

The study is running across 9 research centres. For a list of these and for further details, please visit the Synexus website: www.synexusclinic.co.uk/uc

If you are interested and would like more information about the study, please email patientoutreach@synexus.com 


This research study is NOT funded or organised by Crohn's & Colitis UK and, therefore, we cannot take responsibility for your involvement in the research. It is a patient’s choice to take part.